{"version":"1.0","provider_name":"Nazca","provider_url":"https:\/\/www.nazca.es\/en\/","author_name":"nazcaEstra","author_url":"https:\/\/www.nazca.es\/en\/noticias\/author\/nazcaestra\/","title":"Nazca acquires a majority shareholding in Diater | Nazca","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"v3RVCfGnuN\"><a href=\"https:\/\/www.nazca.es\/en\/noticias\/nazca-adquiere-una-participacion-mayoritaria-en-diater\/\">Nazca acquires a majority shareholding in Diater<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nazca.es\/en\/noticias\/nazca-adquiere-una-participacion-mayoritaria-en-diater\/embed\/#?secret=v3RVCfGnuN\" width=\"600\" height=\"338\" title=\"&#8220;Nazca acquires a majority shareholding in Diater&#8221; &#8212; Nazca\" data-secret=\"v3RVCfGnuN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.nazca.es\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.nazca.es\/wp-content\/uploads\/2019\/07\/Junio_2019_interior.jpg","thumbnail_width":825,"thumbnail_height":332,"description":"Through Nazca Fund IV, Nazca Capital has purchased the shareholding of Laboratorios Ferrer in Diater, a pioneering Spanish biopharmaceutical company in the sector of immunotherapy treatment of allergies. The founders, Dr Ricardo Palacios (president) and Jos\u00e9 \u00c1ngel L\u00f3pez (CEO) participated in the operation, reinvesting all their shares in Diater. Founded in 1999, Diater is specialised [&hellip;]"}